Dr Mansukh Mandaviya, Hon’ble Minister for Health and Family Welfare & Chemicals and Fertilisers, Government of India, presented his address during the closing ceremony, at the 8th edition of Global Pharmaceutical Quality Summit. The Summit’s theme was “Patient Centricity: A New Paradigm of Manufacturing and Quality,” that brought together industry executives, global regulators, quality experts, and stakeholders to stimulate knowledge exchange and deliberate on issues critical to developing India’s pharmaceutical environment.

Dr. Mansukh Mandaviya, said, “Quality, R&D and innovation are the need of the hour. India was in mission mode during COVID-19, and we played a sterling role as the pharmacy of the world, by ensuring an uninterrupted supply of quality medicines and vaccines to the world. In a global crisis, India displayed maturity, responsibility, and leadership. I am happy that collaboration among the Government and stakeholders enhanced India’s global reputation further. I am also deeply appreciative of our pharma industry leaders who placed duty above profit and worked with the Government to fulfil domestic and global demand to manufacture four novels COVID vaccines. It is now time for change. Today, the world wants India to manufacture medicines and vaccines and we must leverage this unique opportunity by using our brand power and manpower. Quality is a top priority today and central and state regulators are working closely to ensure this. Let us collaborate and create new models to foster innovation and strengthen industry-academia linkages. I am hopeful that the Global Pharmaceutical Quality Summit 2023 deliberations over the last two days lead to new pathways to address challenges and a consultative approach is the way forward.”

Regulators from around the world gathered to discuss regulatory affairs, highlighting current inspection observations and trends. The day finished with discussions on technological architecture, focusing on best-in-class engineering controls to assure pharmaceutical production quality.

On the second day of the conference, industry executives discussed industry innovations, continuous manufacturing, regulatory expectations, digital technology in pharmaceutical manufacturing, and lessons learned from other industries. The day’s centrepiece was a panel discussion with senior pharma CEOs from Cipla, Dr Reddy’s, Lupin, Sun Pharma, and Zydus discussing the future of the Indian pharmaceutical business.

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, said, “The Indian pharmaceutical industry plays a critical role in shaping the health outcomes of patients globally. India is known for providing quality-assured affordable medicines worldwide. During the COVID-19 pandemic, the industry demonstrated resilience and is now known as the pharmacy of the world. Quality is the fundamental tenet of the pharmaceutical sector. Continuous investments in quality –systems, technology and talent – is fundamental as the overall healthcare landscape is evolving at an unprecedented pace. IPA is committed to making India a global benchmark in quality.”

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!